Thompson Davis & Co., Inc. Gilead Sciences, Inc. Transaction History

Thompson Davis & Co., Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $74,612 - $84,686	-1,150 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $39,204 - $43,406	550 Added 91.67%	1,150 $89,000
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $6,488 - $7,568	100 Added 20.0%	600 $43,000
Q1 2018 May 02, 2018	SELL	$72.84 - $88.8 $9,105 - $11,100	-125 Reduced 20.0%	500 $38,000
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $10,672 - $12,528	150 Added 31.58%	625 $45,000
Q3 2017 Oct 30, 2017	BUY	$72.11 - $85.47 $14,349 - $17,008	199 Added 72.1%	475 $38,000
Q2 2017 Aug 10, 2017	BUY	N/A	276	276 $20,000

1,902

1.02B

12M

9.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.